Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
August 8, 2016
LOUISVILLE, Ky., Aug. 8, 2016 – Apellis Pharmaceuticals, Inc., a clinical stage complement immunotherapy company, announced today the expansion of its executive team with the addition of Dr.